Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia

被引：0

作者：

Pozzato, G

Zorat, F

Nascimben, F

Comar, C

Kikic, F

Festini, G

机构：

[1] Univ Trieste, Sch Med, Dept Internal Med & Neurol, Trieste, Italy

[2] Cattinara Gen Hosp, Dept Med 1, Trieste, Italy

来源：

HAEMATOLOGICA | 2001年 / 86卷 / 07期

关键词：

thalidomide; myelofibrosis; MMM;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：772 / 773

页数：2

共 10 条

[1] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[2] TRANSFORMING GROWTH-FACTOR-BETA AND MEGAKARYOCYTES IN THE PATHOGENESIS OF IDIOPATHIC MYELOFIBROSIS [J].

MARTYRE, MC ;

ROMQUIN, N ;

LEBOUSSEKERDILES, MC ;

CHEVILLARD, S ;

BENYAHIA, B ;

DUPRIEZ, B ;

DEMORY, JL ;

BAUTERS, F .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (01) :9-16

[3] Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis [J].

Martyre, MC ;

LeBousseKerdiles, MC ;

Romquin, N ;

Chevillard, S ;

Praloran, V ;

Demory, JL ;

Dupriez, B .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :441-448

[4]

Mesa RA, 1999, BLOOD, V94, p115A

[5]

Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO

[6]

2-I

[7] Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia [J].

Tefferi, A ;

Elliott, MA .

BLOOD, 2000, 96 (12) :4007-4007

[8] SURAMIN TOXICITY AND EFFICACY IN AGNOGENIC MYELOID METAPLASIA [J].

TEFFERI, A ;

SILVERSTEIN, MN ;

PLUMHOFF, EA ;

REID, JM ;

AMES, MM .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18) :1520-1522

[9]

Thomas DA, 1999, BLOOD, V94, p702A

[10] Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia [J].

Yoon, SY ;

Li, CY ;

Mesa, RA ;

Tefferi, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) :682-688

← 1 →